
Perspectives on Talquetamab and its Utility in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy
Introduction Multiple myeloma is the second most common blood cancer in the United States, with an estimated 35,780 new diagnoses projected in 2024.1 Despite marked improvements in survival over the past two decades with incorporation of novel classes of …